High Performance Medical Plastics Market
PUBLISHED: 2021 ID: SMRC20786
SHARE
SHARE

High Performance Medical Plastics Market

High Performance Medical Plastics Market Forecasts to 2028 – Global Analysis By Type (Polyphenylene Sulfide (PPS), Polyetherimide (PEI)), Application (Drug Delivery, Medical Equipment) and By Geography

4.1 (41 reviews)
4.1 (41 reviews)
Published: 2021 ID: SMRC20786

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global High Performance Medical Plastics Market is accounted for $789.42 million in 2020 and is expected to reach $1,667.74 million by 2028 growing at a CAGR of 9.8% during the forecast period. The increasing use of high-performance medical plastics is the major factor driving the market growth. However, the time-consuming regulatory approval process is hampering market growth.

High performance plastics are particularly designed polymers with high mechanical strength, chemical resistance, and most importantly, temperature resistance.

Based on the application, the medical equipment & tools segment is going to have lucrative growth during the forecast period. This is attributed to an increase in demand for 3D printing high performance plastics in medical devices.

By geography, North America is going to have high growth during the forecast period. The medical devices market in North America is highly diversified and offers a variety of products to diagnose and treat patients, ranging from medical catheters to vascular grafts and implants.

Some of the key players profiled in the High Performance Medical Plastics Market include Arkema SA, Celanese Corporation, DuPont , Ensinger, Evonik Industries AG, Mitsubishi Chemical Corporation, Raumedic AG, Rochling SE & Co. AG, SABIC, Saint-Gobain Performance Plastics , Solvay SA, Tekni-Plex, The Chemours Company, Trelleborg, and Victrex PLC.

Report Coverage

Details

Published Year:

2021

Estimated Market Size in 2020:

USD 789.42 million

Estimated Period:

2020

Compound Annual Growth Rate (CAGR) from2020 to 2028:

9.8%

Predicted 2028 Value:

USD 1,667.74 million

Forecast Years:

2021-2028

Tables, Graphs& Figures

80

Chapters Covered:

Type, Application and Region

Core Drivers and Opportunities:

  • Growing healthcare investments in emerging economies
  • Rising geriatric population
  • Shift toward minimally invasive medical procedures

Restraining Factors & Market Threats:

  • Time-consuming regulatory approval process
  • Waste management concerns

 
Types Covered:
• Polyphenylene Sulfide (PPS) 
• Polyetherimide (PEI) 
• Polyaryletherketone (PAEK) 
• High Performance Polyamides (HPPA) 
• Fluoropolymers (FP) 

Applications Covered:
• Drug Delivery 
• Medical Equipment & Tools 
• Medical Supplies 
• Prosthesis & Implants 
• Therapeutic System     
  
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Key Questions Answered In The Report

The Global High Performance Medical Plastics Market is majorly driven by rising geriatric population, increasing use of high-performance medical plastics in advanced medical technology, and growing healthcare investments in emerging economies.

The fluropolymers (FP) segment is growing at a highest CAGR due to their extensive use in medical supplies such as catheters, vascular grafts, reusable syringes, dialyzers, and surgical instruments, among others.

North America dominated with a significant market share due to the factors such as technological advancements in design and manufacturing, existing medical device manufacturers in the region, and product modernization in terms of quality and application development.

Asia Pacific market is growing at a highest CAGR due to the increasing demand for medical devices & their associated products, and growing industrialization in emerging countries such as India and China.

Key players in High Performance Medical Plastics Market include Arkema SA, Celanese Corporation, DuPont, Ensinger, Evonik Industries AG, Mitsubishi Chemical Corporation, Raumedic AG, Rochling SE & Co. AG, SABIC, Saint-Gobain Performance Plastics, Solvay SA, Tekni-Plex, The Chemours Company, Trelleborg, and Victrex PLC.

Table of Contents

1 Executive Summary       
        
2 Preface    
    
 2.1 Abstract      
 2.2 Stake Holders      
 2.3 Research Scope      
 2.4 Research Methodology      
  2.4.1 Data Mining     
  2.4.2 Data Analysis     
  2.4.3 Data Validation     
  2.4.4 Research Approach     
 2.5 Research Sources       
  2.5.1 Primary Research Sources     
  2.5.2 Secondary Research Sources     
  2.5.3 Assumptions     
        
3 Market Trend Analysis       
 3.1 Introduction      
 3.2 Drivers      
 3.3 Restraints      
 3.4 Opportunities      
 3.5 Threats      
 3.6 Application Analysis      
 3.7 Emerging Markets      
 3.8 Impact of Covid-19      
        
4 Porters Five Force Analysis       
 4.1 Bargaining power of suppliers      
 4.2 Bargaining power of buyers      
 4.3 Threat of substitutes      
 4.4 Threat of new entrants      
 4.5 Competitive rivalry      
        
5 Global High Performance Medical Plastics Market, By Type       
 5.1 Introduction      
 5.2 Polyphenylene Sulfide (PPS)      
 5.3 Polyetherimide (PEI)      
 5.4 Polyaryletherketone (PAEK)      
 5.5 High Performance Polyamides (HPPA)      
 5.6 Fluoropolymers (FP)      
        
6 Global High Performance Medical Plastics Market, By Application       
 6.1 Introduction      
 6.2 Drug Delivery      
 6.3 Medical Equipment & Tools      
 6.4 Medical Supplies      
 6.5 Prosthesis & Implants      
 6.6 Therapeutic System      
        
7 Global High Performance Medical Plastics Market, By Geography       
 7.1 Introduction      
 7.2 North America      
  7.2.1 US     
  7.2.2 Canada     
  7.2.3 Mexico     
 7.3 Europe      
  7.3.1 Germany     
  7.3.2 UK     
  7.3.3 Italy     
  7.3.4 France     
  7.3.5 Spain     
  7.3.6 Rest of Europe     
 7.4 Asia Pacific      
  7.4.1 Japan     
  7.4.2 China     
  7.4.3 India     
  7.4.4 Australia     
  7.4.5 New Zealand     
  7.4.6 South Korea     
  7.4.7 Rest of Asia Pacific     
 7.5 South America      
  7.5.1 Argentina     
  7.5.2 Brazil     
  7.5.3 Chile     
  7.5.4 Rest of South America     
 7.6 Middle East & Africa      
  7.6.1 Saudi Arabia     
  7.6.2 UAE     
  7.6.3 Qatar     
  7.6.4 South Africa     
  7.6.5 Rest of Middle East & Africa     
        
8 Key Developments       
 8.1 Agreements, Partnerships, Collaborations and Joint Ventures      
 8.2 Acquisitions & Mergers      
 8.3 New Product Launch      
 8.4 Expansions      
 8.5 Other Key Strategies      
        
9 Company Profiling       
 9.1 Arkema SA      
 9.2 Celanese Corporation      
 9.3 DuPont      
 9.4 Ensinger      
 9.5 Evonik Industries AG      
 9.6 Mitsubishi Chemical Corporation      
 9.7 Raumedic AG      
 9.8 Rochling SE & Co. AG      
 9.9 SABIC      
 9.10 Saint-Gobain Performance Plastics      
 9.11 Solvay SA       
 9.12 Tekni-Plex      
 9.13 The Chemours Company      
 9.14 Trelleborg      
 9.15 Victrex PLC      


List of Data Tables        
1 Global High Performance Medical Plastics Market Outlook, By Region (2019-2028) ($MN)       
2 Global High Performance Medical Plastics Market Outlook, By Type (2019-2028) ($MN)       
3 Global High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (PPS) (2019-2028) ($MN)       
4 Global High Performance Medical Plastics Market Outlook, By Polyetherimide (PEI) (2019-2028) ($MN)       
5 Global High Performance Medical Plastics Market Outlook, By Polyaryletherketone (PAEK) (2019-2028) ($MN)       
6 Global High Performance Medical Plastics Market Outlook, By High Performance Polyamides (HPPA) (2019-2028) ($MN)       
7 Global High Performance Medical Plastics Market Outlook, By Fluoropolymers (FP) (2019-2028) ($MN)       
8 Global High Performance Medical Plastics Market Outlook, By Application (2019-2028) ($MN)       
9 Global High Performance Medical Plastics Market Outlook, By Drug Delivery (2019-2028) ($MN)       
10 Global High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2019-2028) ($MN)       
11 Global High Performance Medical Plastics Market Outlook, By Medical Supplies (2019-2028) ($MN)       
12 Global High Performance Medical Plastics Market Outlook, By Prosthesis & Implants (2019-2028) ($MN)       
13 Global High Performance Medical Plastics Market Outlook, By Therapeutic System (2019-2028) ($MN)       
14 North America High Performance Medical Plastics Market Outlook, By Country (2019-2028) ($MN)       
15 North America High Performance Medical Plastics Market Outlook, By Type (2019-2028) ($MN)       
16 North America High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (PPS) (2019-2028) ($MN)       
17 North America High Performance Medical Plastics Market Outlook, By Polyetherimide (PEI) (2019-2028) ($MN)       
18 North America High Performance Medical Plastics Market Outlook, By Polyaryletherketone (PAEK) (2019-2028) ($MN)       
19 North America High Performance Medical Plastics Market Outlook, By High Performance Polyamides (HPPA) (2019-2028) ($MN)       
20 North America High Performance Medical Plastics Market Outlook, By Fluoropolymers (FP) (2019-2028) ($MN)       
21 North America High Performance Medical Plastics Market Outlook, By Application (2019-2028) ($MN)       
22 North America High Performance Medical Plastics Market Outlook, By Drug Delivery (2019-2028) ($MN)       
23 North America High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2019-2028) ($MN)       
24 North America High Performance Medical Plastics Market Outlook, By Medical Supplies (2019-2028) ($MN)        
25 North America High Performance Medical Plastics Market Outlook, By Prosthesis & Implants (2019-2028) ($MN)       
26 North America High Performance Medical Plastics Market Outlook, By Therapeutic System (2019-2028) ($MN)       
27 Europe High Performance Medical Plastics Market Outlook, By Country (2019-2028) ($MN)       
28 Europe High Performance Medical Plastics Market Outlook, By Type (2019-2028) ($MN)       
29 Europe High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (PPS) (2019-2028) ($MN)       
30 Europe High Performance Medical Plastics Market Outlook, By Polyetherimide (PEI) (2019-2028) ($MN)       
31 Europe High Performance Medical Plastics Market Outlook, By Polyaryletherketone (PAEK) (2019-2028) ($MN)        
32 Europe High Performance Medical Plastics Market Outlook, By High Performance Polyamides (HPPA) (2019-2028) ($MN)       
33 Europe High Performance Medical Plastics Market Outlook, By Fluoropolymers (FP) (2019-2028) ($MN)       
34 Europe High Performance Medical Plastics Market Outlook, By Application (2019-2028) ($MN)       
35 Europe High Performance Medical Plastics Market Outlook, By Drug Delivery (2019-2028) ($MN)       
36 Europe High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2019-2028) ($MN)       
37 Europe High Performance Medical Plastics Market Outlook, By Medical Supplies (2019-2028) ($MN)       
38 Europe High Performance Medical Plastics Market Outlook, By Prosthesis & Implants (2019-2028) ($MN)        
39 Europe High Performance Medical Plastics Market Outlook, By Therapeutic System (2019-2028) ($MN)       
40 Asia Pacific High Performance Medical Plastics Market Outlook, By Country (2019-2028) ($MN)       
41 Asia Pacific High Performance Medical Plastics Market Outlook, By Type (2019-2028) ($MN)       
42 Asia Pacific High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (PPS) (2019-2028) ($MN)       
43 Asia Pacific High Performance Medical Plastics Market Outlook, By Polyetherimide (PEI) (2019-2028) ($MN)       
44 Asia Pacific High Performance Medical Plastics Market Outlook, By Polyaryletherketone (PAEK) (2019-2028) ($MN)       
45 Asia Pacific High Performance Medical Plastics Market Outlook, By High Performance Polyamides (HPPA) (2019-2028) ($MN)       
46 Asia Pacific High Performance Medical Plastics Market Outlook, By Fluoropolymers (FP) (2019-2028) ($MN)       
47 Asia Pacific High Performance Medical Plastics Market Outlook, By Application (2019-2028) ($MN)        
48 Asia Pacific High Performance Medical Plastics Market Outlook, By Drug Delivery (2019-2028) ($MN)       
49 Asia Pacific High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2019-2028) ($MN)       
50 Asia Pacific High Performance Medical Plastics Market Outlook, By Medical Supplies (2019-2028) ($MN)       
51 Asia Pacific High Performance Medical Plastics Market Outlook, By Prosthesis & Implants (2019-2028) ($MN)       
52 Asia Pacific High Performance Medical Plastics Market Outlook, By Therapeutic System (2019-2028) ($MN)       
53 South America High Performance Medical Plastics Market Outlook, By Country (2019-2028) ($MN)       
54 South America High Performance Medical Plastics Market Outlook, By Type (2019-2028) ($MN)       
55 South America High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (PPS) (2019-2028) ($MN)       
56 South America High Performance Medical Plastics Market Outlook, By Polyetherimide (PEI) (2019-2028) ($MN)       
57 South America High Performance Medical Plastics Market Outlook, By Polyaryletherketone (PAEK) (2019-2028) ($MN)       
58 South America High Performance Medical Plastics Market Outlook, By High Performance Polyamides (HPPA) (2019-2028) ($MN)       
59 South America High Performance Medical Plastics Market Outlook, By Fluoropolymers (FP) (2019-2028) ($MN)       
60 South America High Performance Medical Plastics Market Outlook, By Application (2019-2028) ($MN)       
61 South America High Performance Medical Plastics Market Outlook, By Drug Delivery (2019-2028) ($MN)       
62 South America High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2019-2028) ($MN)       
63 South America High Performance Medical Plastics Market Outlook, By Medical Supplies (2019-2028) ($MN)       
64 South America High Performance Medical Plastics Market Outlook, By Prosthesis & Implants (2019-2028) ($MN)       
65 South America High Performance Medical Plastics Market Outlook, By Therapeutic System (2019-2028) ($MN)       
66 Middle East & Africa High Performance Medical Plastics Market Outlook, By Country (2019-2028) ($MN)       
67 Middle East & Africa High Performance Medical Plastics Market Outlook, By Type (2019-2028) ($MN)       
68 Middle East & Africa High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (PPS) (2019-2028) ($MN)       
69 Middle East & Africa High Performance Medical Plastics Market Outlook, By Polyetherimide (PEI) (2019-2028) ($MN)       
70 Middle East & Africa High Performance Medical Plastics Market Outlook, By Polyaryletherketone (PAEK) (2019-2028) ($MN)       
71 Middle East & Africa High Performance Medical Plastics Market Outlook, By High Performance Polyamides (HPPA) (2019-2028) ($MN)        
72 Middle East & Africa High Performance Medical Plastics Market Outlook, By Fluoropolymers (FP) (2019-2028) ($MN)       
73 Middle East & Africa High Performance Medical Plastics Market Outlook, By Application (2019-2028) ($MN)       
74 Middle East & Africa High Performance Medical Plastics Market Outlook, By Drug Delivery (2019-2028) ($MN)       
75 Middle East & Africa High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2019-2028) ($MN)       
76 Middle East & Africa High Performance Medical Plastics Market Outlook, By Medical Supplies (2019-2028) ($MN)       
77 Middle East & Africa High Performance Medical Plastics Market Outlook, By Prosthesis & Implants (2019-2028) ($MN)       
78 Middle East & Africa High Performance Medical Plastics Market Outlook, By Therapeutic System (2019-2028) ($MN)       

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials